89bio amends bylaws to tighten stockholder nomination rules and align with Delaware law

89bio, Inc.

Enhanced procedural and disclosure requirements for stockholder director nominations and business proposals, including compliance with SEC Rule 14a-19.
Stockholder nominating directors must represent intent to solicit proxies for non-company nominees and provide compliance evidence.
Virtual stockholder meeting logistics clarified; requirement to open stockholder list at meetings eliminated per DGCL updates.
Company may disregard nominations that do not meet updated requirements or fail to provide required information.
Amendment effective November 9, 2023; board adopted Third Amended and Restated Bylaws.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

89bio, Inc.: Amended and restated bylaws to enhance procedural requirements for stockholder proposals and director nominations, align with Rule 14a-19, and update provisions per DGCL amendments (effective 2023-11-09).

Change: bylaw amendment
Effective: 2023-11-09

Exact text from the filing

On November 9, 2023, the Board of Directors (the “Board”) of 89bio, Inc. (the “Company”) adopted an amendment and restatement of the Company’s Second Amended and Restated Bylaws (as so amended and restated, the “Third Amended and Restated Bylaws”), effective as of such date

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001193125-23-277141

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.